Verastem (VSTM) Free Cash Flow (2011 - 2026)
Verastem's (VSTM) quarterly Free Cash Flow came in at -$52.1 million in Q1 2026, down 34.75% year-on-year from -$79.9 million in Q1 2025, and down 73.99% quarter-over-quarter from -$30.0 million in Q4 2025.
Verastem (VSTM) Free Cash Flow (2011 - 2026) Analysis & Trends
Verastem's Free Cash Flow history runs 16 years deep, the most recent figure standing at -$52.1 million for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 34.75% year-over-year to -$52.1 million in Q1 2026; TTM through Mar 2026 was -$150.9 million, a 31.08% decrease from a year earlier, with the FY2025 full-year figure at -$137.5 million, down 31.21% from the prior year.
- Free Cash Flow declined to -$52.1 million in Q1 2026 per VSTM's latest filing, from -$30.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$12.7 million in Q2 2022 and bottomed at -$52.1 million in Q1 2026.
- The 5-year median for Free Cash Flow is -$25.1 million (2024), against an average of -$26.2 million.
- Across the five-year window, Free Cash Flow sank 78.63% in 2023 and grew 15.44% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$16.6 million in 2022, then sank by 78.63% to -$29.7 million in 2023, then rose by 15.44% to -$25.1 million in 2024, then declined by 19.34% to -$30.0 million in 2025, then tumbled by 73.99% to -$52.1 million in 2026.
- Per Business Quant, the three latest VSTM Free Cash Flow figures stand at -$52.1 million (Q1 2026), -$30.0 million (Q4 2025), and -$36.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -52.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.12 Mn |
| Mar 31, 2026 | -52.12 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Jun 30, 2024 | -27.59 Mn |
| Jun 30, 2024 | -27.59 Mn |
| Mar 31, 2024 | -28.31 Mn |
| Mar 31, 2024 | -28.31 Mn |
| Dec 31, 2023 | -29.68 Mn |
| Dec 31, 2023 | -29.68 Mn |